» Articles » PMID: 23136427

Neurodevelopmental Role for VGLUT2 in Pyramidal Neuron Plasticity, Dendritic Refinement, and in Spatial Learning

Overview
Journal J Neurosci
Specialty Neurology
Date 2012 Nov 9
PMID 23136427
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The level and integrity of glutamate transmission during critical periods of postnatal development plays an important role in the refinement of pyramidal neuron dendritic arbor, synaptic plasticity, and cognition. Presently, it is not clear how excitatory transmission via the two predominant isoforms of the vesicular glutamate transporter (VGLUT1 and VGLUT2) participate in this process. To assess a neurodevelopmental role for VGLUT2 in pyramidal neuron maturation, we generated recombinant VGLUT2 knock-out mice and inactivated VGLUT2 throughout development using Emx1-Cre(+/+) knock-in mice. We show that VGLUT2 deficiency in corticolimbic circuits results in reduced evoked glutamate transmission, release probability, and LTD at hippocampal CA3-CA1 synapses during a formative developmental period (postnatal days 11-14). In adults, we find a marked reduction in the amount of dendritic arbor across the span of the dendritic tree of CA1 pyramidal neurons and reduced long-term potentiation and levels of synaptic markers spinophilin and VGLUT1. Loss of dendritic arbor is accompanied by corresponding reductions in the number of dendritic spines, suggesting widespread alterations in synaptic connectivity. Conditional VGLUT2 knock-out mice exhibit increased open-field exploratory activity yet impaired spatial learning and memory, endophenotypes similar to those of NMDA receptor knock-down mice. Remarkably, the impairment in learning can be partially restored by selectively increasing NMDA receptor-mediated glutamate transmission in adult mice by prolonged treatment with d-serine and a d-amino acid oxidase inhibitor. Our data indicate that VGLUT2 expression is pivotal to the proper development of mature pyramidal neuronal architecture and plasticity, and that such glutamatergic deficiency leads to cognitive malfunction as observed in several neurodevelopmental psychiatric disorders.

Citing Articles

A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to....

Hibicke M, Kramer H, Nichols C Psychedelic Med (New Rochelle). 2025; 1(1):54-67.

PMID: 40047006 PMC: 11661400. DOI: 10.1089/psymed.2022.0012.


Overabundant endocannabinoids in neurons are detrimental to cognitive function.

Zhu D, Zhang J, Ma X, Hu M, Gao F, Hashem J bioRxiv. 2024; .

PMID: 39345517 PMC: 11430108. DOI: 10.1101/2024.09.17.613513.


CPT2 Deficiency Modeled in Zebrafish: Abnormal Neural Development, Electrical Activity, Behavior, and Schizophrenia-Related Gene Expression.

Baker C, Marta A, Zimmerman N, Korade Z, Mathy N, Wilton D Biomolecules. 2024; 14(8).

PMID: 39199302 PMC: 11353230. DOI: 10.3390/biom14080914.


CPEB2-activated axonal translation of VGLUT2 mRNA promotes glutamatergic transmission and presynaptic plasticity.

Lu W, Chang T, Chang Y, Liu Y, Lin C, Suen C J Biomed Sci. 2024; 31(1):69.

PMID: 38992696 PMC: 11241979. DOI: 10.1186/s12929-024-01061-2.


D-ꞵ-hydroxybutyrate stabilizes hippocampal CA3-CA1 circuit during acute insulin resistance.

Kula B, Antal B, Weistuch C, Gackiere F, Barre A, Velado V PNAS Nexus. 2024; 3(5):pgae196.

PMID: 38818236 PMC: 11138115. DOI: 10.1093/pnasnexus/pgae196.


References
1.
Nagerl U, Eberhorn N, Cambridge S, Bonhoeffer T . Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron. 2004; 44(5):759-67. DOI: 10.1016/j.neuron.2004.11.016. View

2.
Goff D, Tsai G, Manoach D, Flood J, Darby D, Coyle J . D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry. 1996; 153(12):1628-30. DOI: 10.1176/ajp.153.12.1628. View

3.
Martina M, Gorfinkel Y, Halman S, Lowe J, Periyalwar P, Schmidt C . Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol. 2004; 557(Pt 2):489-500. PMC: 1665089. DOI: 10.1113/jphysiol.2004.063321. View

4.
Halasy K, Hajszan T, Kovacs E, Lam T, Leranth C . Distribution and origin of vesicular glutamate transporter 2-immunoreactive fibers in the rat hippocampus. Hippocampus. 2004; 14(7):908-18. DOI: 10.1002/hipo.20006. View

5.
Takamori S, Rhee J, Rosenmund C, Jahn R . Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci. 2001; 21(22):RC182. PMC: 6762262. View